Methylphenidate for adults with attention deficit-hyperactivity disorder, a systematic review

被引：0
|
作者：
Epstein, T. [1 ]
Patsopoulos, N. A. [2 ]
Weiser, M. [1 ]
机构：
[1] Sheba Med Ctr, Ramat Gan, Israel
[2] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2009年 / 19卷
关键词：
D O I：
10.1016/S0924-977X(09)70515-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S341 / S341
页数：1
相关论文
共 50 条
  • [31] Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder
    Cortese, Samuele
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (11): : 1050 - 1056
  • [32] Effects of methylphenidate on driving ability in adults with attention deficit hyperactivity disorder
    Volkerts, E. R.
    Bekker, E. M.
    De Roos, M.
    Minova, A.
    Eijken, E. J. E.
    Kooij, J. J. S.
    Buitelaar, J. K.
    Kenemans, J. L.
    Verbaten, M. N.
    Olivier, B.
    Verster, J. C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S252 - S252
  • [33] OROS*-Methylphenidate and executive functioning in adults with attention deficit hyperactivity disorder
    Fallu, A.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : XCIII - XCIII
  • [34] OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder
    Antoni Ramos-Quiroga, J.
    Corominas, Margarida
    Castells, Xavier
    Bosch, Rosa
    Casas, Miguel
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (08) : 1121 - 1131
  • [35] Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders
    Simon, Nicolas
    Rolland, Benjamin
    Karila, Laurent
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (23) : 3359 - 3366
  • [36] Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder
    Levin, ED
    Conners, CK
    Silva, D
    Canu, W
    March, J
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2001, 9 (01) : 83 - 90
  • [37] The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder
    Sopko, Michael A., Jr.
    Caberwal, Harjeet
    Chavez, Benjamin
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2010, 2 : 15 - 30
  • [38] Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder
    Olfson, Mark
    Marcus, Steven C.
    Zhang, Huabin F.
    Wan, George J.
    JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (07): : 570 - 577
  • [39] Adverse reactions of methylphenidate in children with attention deficit-hyperactivity disorder: report from a referral center
    Faghihi, T.
    Khalili, H.
    Khajehpiri, Z.
    Gharaei, J. Mahmoudi
    Karimzadeh, I.
    Mohammadi, M.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2015, 24 : S178 - S178
  • [40] Methylphenidate for Attention-Deficit/Hyperactivity Disorder
    Romanos, Marcel
    Reif, Andreas
    Banaschewski, Tobias
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (09): : 994 - 995
12345